Corteva (NYSE:CTVA) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Corteva (NYSE:CTVA) had its price target raised by analysts at Royal Bank Of Canada from $89.00 to $95.00 in a research report issued on Friday, MarketBeat reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective indicates a potential upside of 19.07% from the stock’s previous close.

CTVA has been the topic of a number of other research reports. BNP Paribas Exane raised their target price on shares of Corteva from $72.00 to $74.00 in a research note on Monday, March 9th. Jefferies Financial Group raised their price target on shares of Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Mizuho raised their price target on shares of Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Bank of America raised their price target on shares of Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a report on Thursday, January 8th. Finally, Citigroup raised their price target on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.19.

Corteva Stock Performance

Shares of CTVA stock opened at $79.78 on Friday. The company’s fifty day simple moving average is $80.09 and its 200-day simple moving average is $71.64. Corteva has a 52 week low of $60.53 and a 52 week high of $85.63. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market cap of $53.56 billion, a PE ratio of 50.50, a P/E/G ratio of 2.73 and a beta of 0.68.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter last year, the firm posted $0.32 EPS. The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts anticipate that Corteva will post 3.62 EPS for the current year.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.15% of the company’s stock.

Institutional Investors Weigh In On Corteva

Several hedge funds and other institutional investors have recently modified their holdings of the stock. William B. Walkup & Associates Inc. increased its position in shares of Corteva by 2.9% in the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock worth $373,000 after purchasing an additional 126 shares during the last quarter. AdvisorNet Financial Inc increased its position in shares of Corteva by 2.4% in the 1st quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after purchasing an additional 135 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC increased its position in shares of Corteva by 9.1% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock worth $112,000 after purchasing an additional 140 shares during the last quarter. Eagle Bay Advisors LLC increased its position in shares of Corteva by 4.3% in the 1st quarter. Eagle Bay Advisors LLC now owns 3,721 shares of the company’s stock worth $312,000 after purchasing an additional 153 shares during the last quarter. Finally, Tred Avon Family Wealth LLC increased its position in shares of Corteva by 2.5% in the 1st quarter. Tred Avon Family Wealth LLC now owns 6,248 shares of the company’s stock worth $523,000 after purchasing an additional 154 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.